-
Exclusive: Progenics CEO Talks Regulatory Climate, Positive Trials For Ultra-Orphan Azedra
Monday, April 3, 2017 - 1:58pm | 625From healthcare to finance to natural resources, everyone is reeling from federal administration shakeups and their various market implications. But Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX) CEO Mark Baker is unconcerned by leadership and regulatory changes at the U.S. Food and Drug...
-
Needham Is Bullish On Progenics Pharmaceuticals
Thursday, June 25, 2015 - 3:26pm | 228Tarrytown, New Jersey-based Progenics Pharmaceuticals, Inc. (NASDAQ: PGNX) is engaged in the development of medicines for oncology. Earlier this week, the company achieved a major milestone as it submitted a New Drug Application (NDA) for oral Relistor. Relistor is a treatment for opioid-...
-
Orchard Supply Set to Sell to Lowe's For $205 Million (LOW, OSH)
Monday, June 17, 2013 - 12:27pm | 1169Neighborhood hardware and garden supply chain Orchard Supply (NASDAQ: OSH) announced Monday morning that it would voluntarily file for bankruptcy in an effort to sell itself to Lowe's (NYSE: LOW). Orchard Supply shares initially popped on the news but have since sold off while Lowe's shares gained...